Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-11-21
2006-11-21
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C424S144100
Reexamination Certificate
active
07138243
ABSTRACT:
The present invention relates to a novel protein, termed NTB-A, nucleic acid molecules encoding the same and uses thereof. The invention also relates to methods of regulating Natural Killer cells activity by regulating the activity of NTBA-A in vitro, ex vivo or in vivo. The invention also comprises methods of screening active compounds using NTB-A or fragments thereof, or nucleic acid encoding the same, or recombinant host cells expressing said polypeptide.
REFERENCES:
patent: 2003/0092017 (2003-05-01), Finger
patent: 2003/0180888 (2003-09-01), Fraser
patent: 2004/0005317 (2004-01-01), Dedera et al.
patent: 2004/0009491 (2004-01-01), Birse et al.
patent: 2005/0027114 (2005-02-01), Kuo et al.
patent: WO 01 55336 (2001-08-01), None
EMBL online accession No. AW851581, created May 24, 2000, accessible at http://www.ebi.ac.uk/cgi-bin/emblfetch?style=html&id=aw851581.
Palmieri et al. “NK cell receptors and signalling”, Research in Immunology, 1997, vol. 148, pp. 184-190.
Birse et al. “Nucleic acids, proteins, and antibodies”, WO200190304, 2001, pp. 1-2.
Bottino, C. et al. “NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.”J. Exper. Med. (2001) 194(3):235,246.
Moretta, L. et al. “Human NK-cell receptors.”Immunol. Today(2000) 21(9):420-422.
Moretta, A. et al. “Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis.”Immunol. Today(2000) 21(5):228-234.
Bauer, S. et al. “Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA” Science 285 :727-729, 1999.
Biassoni, R. et al. “CD-3-negative lymphokine-activated cytotoxic cells express the CD3ε gene” J. Immunol. 140:1685-1689, 1988.
Biassoni, R. et al. “The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity” Eur. J. Immunol. 29:1014-1020, 1999.
Boles, K.S. et al. “Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4” Tissue Antigens 54:27-34, 1999.
Bosselut, R. et al. “Association of the adaptor molecule LAT with CD4 and CD8 coreceptors identifies a new coreceptor function in T cell receptor signal transduction” J. Exp. Med. 190(10:1517-1525, 1999.
Bottino, C. et al. “Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: Evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells” Eur. J. Immunol. 30:3718-3722, 2000.
Cantoni, C. et al. “NKp44, a trigerring receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily” J. Exp. Med. 189(5):787-795.
Cantoni, C. et al. “Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells” Eur. J. Immunol. 29:3148-3159, 1999.
Chang, C. et al. “Cutting edge: Kap10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties” J. Immunol. 163:4651-4654, 1999.
Coffey, A. et al. “Host-response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene” Nature Genetics 20:129-135, 1998.
Davis, S.J. and P.A. van der Merwe. “The structure and ligand interactions of CD2: Implications for T-cell function” Immunology Today 17(4):177-187, 1996.
De La Fuente, M.A. et al. “CD84 leukocyte antigen is a new member of the 1g superfamily” Blood 90(6) :2398-2405, 1997.
Garni-Wagner, B.A. et al. “A novel function-associated molecule related to non-MHC-restricted cytotoxocity mediated by activated natural killer cells and T cells” J. Immunol. 151:60-70, 1993.
Garrido, F. et al. “Implications for immunosurveillance of altered HLA class I phenotypes in human tumours” Immunol. Today 18(2):89-95, 1997.
Houchins, J.P. “DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cell” J. Exp. Med. 173:1017-1020, 1991.
Kubin, M. et al. “Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48” Eur. J. Immunol. 29:3466-3477, 1999.
Lanier, L.L. “NK cell receptors” Annu. Rev. Immunol. 16:359-393, 1998.
Long, E.O. “Regulation of immune responses through inhibitory receptors” Annu. Rev. Immunol. 17:875-904, 1999.
Masucci, M.G. et al. “Down-regulation of class I HLA antigens and the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines” Proc. Natl. Acad. Sci. USA 84:4567-4571, 1987.
Matthew, P.A. et al. “Cloning an dcharacterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells” J. Immunol. 151:5328-5337, 1993.
Mavaddat, N. et al. “Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity” J. Biol. Chem. 275(36):28100-28109, 2000.
Morra, M. et al. “X-linked lymphoproliferative disease: A progressive immunodeficiency” Annu. Rev. Immunol. 19:657-682, 2001.
Moretta, A. et al. “Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery” Int. J. Cancer Suppl. 7:6-10, 1992.
Moretta, A. et al. “Receptors for HLA class-I molecules in human natural killer cells” Annu. Rev. Immunol. 14:619-648, 1996.
Moretta, A. et al. “Natural cytotoxicity receptors that trgger human NK-cell-mediated cytolysis” Immunol. Today 21:228-234, 2000.
Moretta, A. et al. “Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis” Annu. Rev. Immunol. 19:197-223, 2001.
Nakajima, H. et al. “Activating interations in human NK cell recognition: The role of 2B4-CD48” Eur. J. Immunol. 29:1676-1683, 1999.
Nakajima, H. et al. “Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity” Eur. J. Immunol. 30:3309-3318, 2000.
Nichols, K.E. et al. “Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome” Proc. Natl. Acad. Sci. USA 95:13765-13770, 1998.
Parolini, S. et al. “X-linked lymphoproliferative diseasse: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells” J. Exp. Med. 192(3):337-346, 2000.
Pende, D. et al. “Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells” J. Exp. Med. 190(10:1505-1516, 1999.
Pende, D. et al. “Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin” Eur. J. Immunol. 31:1076-1086, 2001.
Pessino, A. et al. “Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity” J. Exp. Med. 188(5):953-960, 1998.
Purtillo, D.T. “Fatal infectious mononucleosis in familial lymphohistiocytosis” N. Engl. J. Med. 201:736, 1974.
Rowe, M. et al. “Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-I: Coordinate up-regulation of peptide transporters and HLA-class I antigen expression” Eur. J. Immunol. 25:1374-1384, 1995.
Sayos, J. et al. “The X-linked lymphoproliferative-disease gene product SAP
Biassoni Roberto
Bottino Cristina
Moretta Alessandro
Innate Pharma S.A.
Jung Unsu
Le Long V.
Saliwanchik Lloyd & Saliwanchik
University of Genova
LandOfFree
NTB-A, a surface molecule involved in natural killer cells... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NTB-A, a surface molecule involved in natural killer cells..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NTB-A, a surface molecule involved in natural killer cells... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3660843